HMGB1 and inflammatory bowel disease: We have previously shown in patients with inflammatory bowel disease (IBD) that fecal HMGB1 is a robust non-invasive biomarker of mucosal inflammation and healing, suggesting its potential role in the diagnostic approach and monitoring intestinal inflammation in children (24, 25).